NASDAQ
Day One Biopharmaceuticals, Inc. (DAWN) has a free cash flow growth of -204.03% as of Friday, May 29, 2026. This represents a 65.46% decrease compared to its 12-month average of -123.31%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.